Substance Abuse Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?
Conditions:   Alcohol Abuse;   Alcohol Addiction;   Alcohol Dependence;   Alcohol Use Disorder Interventions:   Drug: Semaglutide Injectable Product;   Drug: Placebo Sponsors:   Psychiatric Centre Rigshospitalet;   Neurobiology Research Unit Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2023 Category: Research Source Type: clinical trials

Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?
Conditions:   Alcohol Abuse;   Alcohol Addiction;   Alcohol Dependence;   Alcohol Use Disorder Interventions:   Drug: Semaglutide Injectable Product;   Drug: Placebo Sponsors:   Psychiatric Centre Rigshospitalet;   Neurobiology Research Unit Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2023 Category: Research Source Type: clinical trials

Randomized, Controlled Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)
Condition:   Alcohol Use Disorder Interventions:   Drug: Semaglutide 3 MG [Rybelsus];   Drug: Semaglutide 7 MG [Rybelsus];   Drug: Placebo Sponsors:   University of Colorado, Denver;   National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2023 Category: Research Source Type: clinical trials

Semaglutide Therapy for Alcohol Reduction - Tulsa
Condition:   Alcohol Use Disorder Interventions:   Drug: Semaglutide;   Drug: Placebo Sponsors:   Oklahoma State University Center for Health Sciences;   National Institute of Drug Abuse Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2023 Category: Research Source Type: clinical trials

Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)
Condition:   Alcohol Use Disorder Interventions:   Drug: Semaglutide 3 MG [Rybelsus];   Drug: Semaglutide 7 MG [Rybelsus];   Drug: Placebo Sponsors:   University of Colorado, Denver;   National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2023 Category: Research Source Type: clinical trials